和黄医药(HCM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HCM 和黄医药

交易中 11-18 12:16:57 EST

16.86

+0.12

+0.72%

最高16.86	最低16.63	成交量1.12万
今开16.84	昨收16.74	日振幅1.37%
总市值28.82亿	流通市值17.53亿	总股本1.71亿
成交额18.83万	换手率0.01%	流通股本1.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HCM","market":"US","secType":"STK","nameCN":"和黄医药","latestPrice":16.86,"timestamp":1731950155329,"preClose":16.74,"halted":0,"volume":11213,"delay":0,"floatShares":104000000,"shares":170928454,"eps":-0.245665,"marketStatus":"交易中","marketStatusCode":2,"change":0.12,"latestTime":"11-18 12:16:57 EST","open":16.84,"high":16.86,"low":16.63,"amount":188307.018042,"amplitude":0.01374,"askPrice":16.9,"askSize":218,"bidPrice":16.86,"bidSize":105,"shortable":3,"etf":0,"ttmEps":-0.245665,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731963600000},"adr":1,"listingDate":1458187200000,"adjPreClose":16.74,"adrRate":5,"postHourTrading":{"tag":"盘后","latestPrice":16.74,"preClose":16.74,"latestTime":"16:01 EST","volume":858,"amount":14362.92,"timestamp":1731704517110},"volumeRatio":0.298868,"impliedVol":1.5583,"impliedVolPercentile":0.992},"requestUrl":"/m/hq/s/HCM","defaultTab":"news","newsList":[{"id":"2483921582","title":"Trinet Group, Inc.盘中异动 下午盘股价大跌5.03%报91.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483921582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483921582?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:53","pubTimestamp":1731700396,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时53分，Trinet Group, Inc.股票出现异动，股价急速下跌5.03%。Trinet Group, Inc.股票所在的人员配备服务行业中，整体跌幅为1.77%。其相关个股中，迦里仕人才、Professional Diversity Network, Inc.、Hirequest, Inc.涨幅较大，Staffing 360 Solutions, Inc.、Professional Diversity Network, Inc.、Nixxy, Inc.较为活跃，换手率分别为12.15%、5.79%、3.02%，振幅较大的相关个股有Professional Diversity Network, Inc.、迦里仕人才、Mastech Digital, Inc，振幅分别为48.33%、25.91%、13.36%。Trinet Group, Inc.公司简介：Trinet Group Inc通过专业雇主组织，为中小型企业提供外包薪资和人力资本管理解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116035317abc57bac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116035317abc57bac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4130","BK4531","BK4585","BK4588","LU2517655028.SGD","TNET","PEO","LU2517655374.HKD","BK4007","LU2517655291.USD","HCM"],"gpt_icon":0},{"id":"2483310169","title":"“天价”ERP项目导致欧洲最大政府破产：预算涨了10倍，上线半年8000多个错误，一年税收没正常过","url":"https://stock-news.laohu8.com/highlight/detail?id=2483310169","media":"InfoQ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483310169?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:30","pubTimestamp":1731655801,"startTime":"0","endTime":"0","summary":"作者 | 冬梅在当今数字化时代，ERP（企业资源规划）系统对于任何组织来说都是至关重要的。一个稳定且功能强大的 ERP 系统能够为企业提供决策支持，提高运营效率，降低成本，并增强企业竞争力。然而，如果 ERP 系统实施不当或管理不善，它也可能成为企业运营的灾难，甚至可能导致财务失控，审计困难，最终引发法律诉讼和破产...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OHlGu1rGtdXZd2-w1tbEAiV36aF_YarGeJrB_IDV5AnBMAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OHlGu1rGtdXZd2-w1tbEAiV36aF_YarGeJrB_IDV5AnBMAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241115A05WB500","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241115A05WB500","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE00BBT3K403.USD","LU1429558221.USD","LU0965509010.AUD","LU0444973449.USD","BK4516","LU0130102774.USD","LU0661504455.SGD","LU0323591593.USD","LU2326559502.SGD","UK","IE0004445239.USD","LU0208291251.USD","LU0068578508.USD","LU0256863811.USD","LU0433182093.SGD","LU0965509283.SGD","HCM","LU1934455277.USD","IE00B19Z3B42.SGD","LU0082616367.USD","BK4585","LU0056508442.USD","LU0198837287.USD","IE0009356076.USD","LU0476273544.USD","LU0965509101.SGD","IE0002270589.USD","LU0348723411.USD","LU0444971666.USD","IE00BMPRXR70.SGD","LU1935042991.SGD","BK4528","BK4205","IE00BN8TJ469.HKD","LU0289960550.SGD","LU0070302665.USD","LU1803068979.SGD","LU1935043536.SGD","IE00B5949003.HKD","LU0980610538.SGD","LU0719512351.SGD","LU0320765489.SGD","LU0965508806.USD","LU1035773651.USD","LU0957808578.USD","LU0985489474.SGD","ORCL","LU1934455194.USD","BK4588","LU1935042488.USD"],"gpt_icon":0},{"id":"2483707860","title":"和黄医药11月13日遭南向资金减持150.93万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483707860","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483707860?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:30","pubTimestamp":1731547805,"startTime":"0","endTime":"0","summary":"11月13日，南向资金减持和黄医药150.93万股。截止当日收盘，港股通共持有和黄医药18031.85万股，占流通股20.68%。和黄医药近5个交易日下跌7.22%，港股通累计减持19.64万股；近20个交易日下跌11.18%，港股通累计减持133.08万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114093014abbf1760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114093014abbf1760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","HCM","00013","BK1587","BK1588"],"gpt_icon":0},{"id":"2483836748","title":"和黄医药(US ADR)下跌2.06%，报17.12美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483836748","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483836748?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:09","pubTimestamp":1731514192,"startTime":"0","endTime":"0","summary":"11月14日，和黄医药(US ADR)(HCM)盘中下跌2.06%，截至00:09，报17.12美元/股，成交24.4万美元。财务数据显示，截至2024年06月30日，和黄医药(US ADR)收入总额3.06亿美元，同比减少42.64%；归母净利润2580.1万美元，同比减少84.69%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/14000945270334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4531","00013","BK1588","BK1587","HCM","BK1191","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2482771377","title":"和黄医药(00013)上涨5.09%，报28.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482771377","media":"金融界","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482771377?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:17","pubTimestamp":1731377864,"startTime":"0","endTime":"0","summary":"11月12日，和黄医药(00013)盘中上涨5.09%，截至10:17，报28.9元/股，成交4778.88万元。和黄医药(中国)有限公司是一家专注于全球市场的创新型医药研发企业，主要业务包括研发、生产、营销和经销抗肿瘤药物、处方药和消费保健产品。公司在全球范围内拥有多个上市药物，并在纳斯达克全球精选市场、香港交易所以及伦敦证交所的AIM市场上市。截至2024年中报，和黄医药营业总收入21.79亿元、净利润1.84亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/12101745180061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4007","BK1191","BK4585","HCM","BK4588","BK1588","BK1587","BK4531","00013"],"gpt_icon":0},{"id":"2482757717","title":"Trinet Group, Inc.盘中异动 下午盘股价大涨5.00%报97.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482757717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482757717?lang=zh_cn&edition=full","pubTime":"2024-11-12 03:53","pubTimestamp":1731354824,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日03时53分，Trinet Group, Inc.股票出现波动，股价大幅上涨5.00%。Trinet Group, Inc.股票所在的人员配备服务行业中，整体涨幅为1.32%。其相关个股中，Mastech Digital, Inc、Trinet Group, Inc.、巴瑞特商业服务公司涨幅较大，Staffing 360 Solutions, Inc.、迦里仕人才、Nixxy, Inc.较为活跃，换手率分别为16.82%、12.16%、1.68%，振幅较大的相关个股有迦里仕人才、Mastech Digital, Inc、Nixxy, Inc.，振幅分别为14.51%、14.30%、10.87%。Trinet Group, Inc.公司简介：Trinet Group Inc通过专业雇主组织，为中小型企业提供外包薪资和人力资本管理解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112035344abb6f00c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112035344abb6f00c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEO","LU2517655028.SGD","HCM","TNET","BK4130","LU2517655291.USD","LU2517655374.HKD","BK4585","BK4007","BK4531","BK4588"],"gpt_icon":0},{"id":"2482735003","title":"和黄医药(US ADR)下跌2.17%，报17.56美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735003","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735003?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:02","pubTimestamp":1731337379,"startTime":"0","endTime":"0","summary":"11月11日，和黄医药(US ADR)(HCM)盘中下跌2.17%，截至23:02，报17.56美元/股，成交24.56万美元。财务数据显示，截至2024年06月30日，和黄医药(US ADR)收入总额3.06亿美元，同比减少42.64%；归母净利润2580.1万美元，同比减少84.69%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/11230245172144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK1588","BK4588","BK4007","BK1587","00013","BK4531","BK4585","HCM","BK1191"],"gpt_icon":0},{"id":"2482212016","title":"南向资金11月8日净买入和黄医药111.69万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2482212016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482212016?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:30","pubTimestamp":1731288606,"startTime":"0","endTime":"0","summary":"11月8日, 南向资金增持和黄医药111.69万股，连续5日增持。截止当日收盘，港股通共持有和黄医药18163.53万股，占流通股20.83%。和黄医药近5个交易日下跌3.08%，港股通累计增持307.04万股；近20个交易日下跌9.57%，港股通累计增持133.84万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111093008a22abd99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111093008a22abd99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK1588","00013","BK1191","BK1587"],"gpt_icon":0},{"id":"2481101112","title":"和黄医药盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101112","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101112?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:42","pubTimestamp":1731076956,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时42分，和黄医药股票出现异动，股价急速跳水5.03%。截至发稿，该股报17.76美元/股，成交量7244股，换手率0.00%，振幅1.95%。和黄医药股票所在的制药行业中，整体涨幅为0.65%。该公司拥有多种抗癌候选药物组合，目前正在全球范围内进行临床研究，并在中国本土市场拥有广泛的商业基础设施。2023年1月，和黄医药将中国之外的全球权益授予武田，交易总额最高可达11.3亿美元，一度刷新了中国小分子新药出海授权的交易纪录。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224237abae42b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224237abae42b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","BK4585","HCM","BK4007","BK4588"],"gpt_icon":0},{"id":"2481169126","title":"中金：维持和黄医药(00013)“跑赢行业”评级 目标价38.25港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169126?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:13","pubTimestamp":1731028396,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研究报告称，维持和黄医药“跑赢行业”评级，公司2024年/2025年EPS预测-0.12元/0.01元不变，目标价38.25港元。10月31日，公司合作方武田公布FY2024 Q2财报，Fruzaqla3Q24销售额111亿日元，符合该行预期。中金主要观点如下：呋喹替尼美国市占率持续提高，即将开启欧洲日本新商业化版图。该行认为Fruzaqla在欧洲和日本mCRC空间同样可观，预计未来有望不断为公司贡献良好的分成收入。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HCM","00013"],"gpt_icon":0},{"id":"2481571913","title":"中国创新药，在美国半年就卖了10个亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2481571913","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481571913?lang=zh_cn&edition=full","pubTime":"2024-11-07 11:04","pubTimestamp":1730948688,"startTime":"0","endTime":"0","summary":"好消息终于在去年11月传来，呋喹替尼在美国成功获批，用于三线及以上结直肠癌的治疗。仅一个月时间，呋喹替尼海外市场销售额1510万美元，今年上半年达到1.305亿美元。在美国获批以后，和黄成功拿到了3500万美元的监管里程碑付款。有机构分析称，截至2024第三季度，呋喹替尼在美国3L市场份额仅10%，4L+市场份额29%，还有非常大的可渗透空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107110700aba84636&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107110700aba84636&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","HCM","BK4588","BK4531","00013"],"gpt_icon":0},{"id":"2481991242","title":"南向资金11月6日净买入和黄医药45.70万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2481991242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481991242?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:30","pubTimestamp":1730943006,"startTime":"0","endTime":"0","summary":"11月6日, 南向资金增持和黄医药45.70万股，连续3日增持。截止当日收盘，港股通共持有和黄医药18051.49万股，占流通股20.70%。和黄医药近5个交易日下跌2.68%，港股通累计减持123.00万股；近20个交易日下跌7.18%，港股通累计增持27.56万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107093014a21e5cb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107093014a21e5cb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","00013","BK4531","BK4007","BK4588","BK4585"],"gpt_icon":0},{"id":"2481000416","title":"Trinet Group, Inc.盘中异动 股价大涨5.18%报88.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481000416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481000416?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903429,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分，Trinet Group, Inc.股票出现异动，股价快速上涨5.18%。Trinet Group, Inc.股票所在的人员配备服务行业中，整体涨幅为0.00%。其相关个股中，Ziprecruiter, Inc.、巴瑞特商业服务公司、Trinet Group, Inc.涨幅较大，Staffing 360 Solutions, Inc.、Nixxy, Inc.、Insperity, Inc.较为活跃，换手率分别为3.44%、0.18%、0.03%，振幅较大的相关个股有巴瑞特商业服务公司、Ziprecruiter, Inc.、Trinet Group, Inc.，振幅分别为2.06%、0.44%、0.00%。Trinet Group, Inc.公司简介：Trinet Group Inc通过专业雇主组织，为中小型企业提供外包薪资和人力资本管理解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223029971a4b59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223029971a4b59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNET","HCM","LU2517655291.USD","BK4007","BK4130","BK4585","LU2517655028.SGD","BK4531","BK4588","LU2517655374.HKD","PEO"],"gpt_icon":0},{"id":"2481616185","title":"和黄医药(00013)将于2024年美国血液学会年会和2024年欧洲肿瘤内科学会亚洲年会公布临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2481616185","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481616185?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:09","pubTimestamp":1730866148,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和黄医药 发布公告，索乐匹尼布 的ESLIM-01 III期研究以及和黄医药自主研发的化合物的数项研究的最新及更新后的数据将于2024年12月7日至10日在美国圣地亚哥召开的2024年美国血液学会 年会，以及2024年12月6日至8日在新加坡召开的2024年欧洲肿瘤内科学会 亚洲年会上公布。至数据截止日2024年1月31日，共179名患者接受了至少一剂索乐匹尼布治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1588","HCM","00013","BK4007","BK4531","BK4588","BK4585","BK1191"],"gpt_icon":0},{"id":"2481169548","title":"和黄医药11月5日获南向资金加仓140.70万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169548?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:30","pubTimestamp":1730856606,"startTime":"0","endTime":"0","summary":"11月5日, 南向资金增持和黄医药140.70万股。截止当日收盘，港股通共持有和黄医药18005.78万股，占流通股20.65%。和黄医药近5个交易日下跌5.65%，港股通累计减持196.95万股；近20个交易日下跌12.43%，港股通累计增持217.17万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106093015a219f010&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106093015a219f010&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","BK1588","BK1191","BK1587","HCM"],"gpt_icon":0},{"id":"2480573317","title":"南向资金11月1日净卖出和黄医药62.40万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2480573317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480573317?lang=zh_cn&edition=full","pubTime":"2024-11-04 09:30","pubTimestamp":1730683806,"startTime":"0","endTime":"0","summary":"11月1日，南向资金减持和黄医药62.40万股连续5日减持。截止当日收盘，港股通共持有和黄医药17856.49万股，占流通股20.48%。和黄医药近5个交易日下跌11.23%，港股通累计减持427.38万股；近20个交易日下跌6.40%，港股通累计增持278.67万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093009ab9c3622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104093009ab9c3622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00013","HCM","BK1587","BK1588"],"gpt_icon":0},{"id":"2480884426","title":"美股异动 | 中概医药股多数上涨 和黄医药(HCM.US)涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884426","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884426?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:03","pubTimestamp":1730469813,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，中概医药股多数上涨，截至发稿，百济神州涨超1%，和黄医药涨5%；众巢医学跌超2%，再鼎医药跌0.5%。消息面上，和黄医药宣布，因FRUZAQLA 用于治疗转移性结直肠癌的销售额超过2亿美元触发，将收到来自合作伙伴武田  的2千万美元里程碑付款。截至2024年9月的九个月内，武田实现 FRUZAQLA 净销售额2.03亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4531","00013","BK1191","BK1161","BK1515","HCM","159938","BK1574","BK4007","BK1587","BK1588","09939","BK4585"],"gpt_icon":0},{"id":"2480027716","title":"港股异动 | 和黄医药(00013)涨超3% 将收到武田2千万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2480027716","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480027716?lang=zh_cn&edition=full","pubTime":"2024-11-01 15:27","pubTimestamp":1730446034,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和黄医药(00013)涨超3%，截至发稿，涨3.7%，报29.45港元，成交额8500.17万港元。消息面上，和黄医药宣布，因FRUZAQLA®(呋喹替尼) 用于治疗转移性结直肠癌的销售额超过2亿美元触发，将收到来自合作伙伴武田 (TSE: 4502/ NYSE: TAK) 的2千万美元里程碑付款。截至2024年9月的九个月内，武田实现 FRUZAQLA® 净销售额2.03亿美元。和黄医药首席执行官兼首席科学官苏慰国博士表示，此次收到2000万美元里程碑付款将进一步巩固公司的资产负债表，期待扩展呋喹替尼用于更多新的适应症，以及在更广泛的管线中推动公司的全球合作战略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","BK4585","HCM","BK4531","BK1191","BK4007","BK1587","BK4588","00013"],"gpt_icon":0},{"id":"2480011371","title":"和黄医药10月31日遭南向资金减持255.60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480011371","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480011371?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:30","pubTimestamp":1730424605,"startTime":"0","endTime":"0","summary":"10月31日，南向资金减持和黄医药255.60万股连续4日减持。截止当日收盘，港股通共持有和黄医药17918.88万股，占流通股20.56%。和黄医药近5个交易日下跌12.62%，港股通累计减持310.60万股；近20个交易日下跌14.20%，港股通累计增持304.27万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101093016ab8eb344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101093016ab8eb344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4007","BK4585","BK4531","00013","HCM"],"gpt_icon":0},{"id":"2480068734","title":"和黄医药(US ADR)下跌5.04%，报17.995美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480068734","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480068734?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:04","pubTimestamp":1730401488,"startTime":"0","endTime":"0","summary":"11月1日，和黄医药(US ADR)(HCM)盘中下跌5.04%，截至03:04，报17.995美元/股，成交183.23万美元。财务数据显示，截至2024年06月30日，和黄医药(US ADR)收入总额3.06亿美元，同比减少42.64%；归母净利润2580.1万美元，同比减少84.69%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/11/01030444814292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["HCM","BK4007","BK1587","BK4585","BK1588","BK4531","BK4588","00013","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hutch-med.com","stockEarnings":[{"period":"1week","weight":-0.0674},{"period":"1month","weight":-0.155},{"period":"3month","weight":-0.0937},{"period":"6month","weight":-0.1701},{"period":"1year","weight":-0.0472},{"period":"ytd","weight":-0.0756}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"和黄医药（中国）有限公司是一间主要从事制造及销售药物的投资控股公司。该公司主要通过两个分部运营业务。肿瘤免疫业务分部从事发现、开发和商业化用于治疗癌症和免疫性疾病的靶向疗法和免疫疗法。其中研发包括涵盖药物发现、开发、生产及监管职能的研发活动，上市产品包括通过研发活动开发的药物的已开具发票的销售、推广、生产及分销。其他业务分部从事其他商业化业务，包括其他处方药物及保健品的销售、推广、生产及分销。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.04629},{"month":2,"riseRate":0.375,"avgChangeRate":-0.008286},{"month":3,"riseRate":0.375,"avgChangeRate":-0.005299},{"month":4,"riseRate":0.555556,"avgChangeRate":0.042359},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.070144},{"month":6,"riseRate":0.666667,"avgChangeRate":0.076759},{"month":7,"riseRate":0.555556,"avgChangeRate":0.038822},{"month":8,"riseRate":0.444444,"avgChangeRate":0.020061},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.025072},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.0009},{"month":11,"riseRate":0.777778,"avgChangeRate":0.12299},{"month":12,"riseRate":0.625,"avgChangeRate":0.007065}],"exchange":"NASDAQ","name":"和黄医药","nameEN":"Hutchison China Meditech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和黄医药(HCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和黄医药(HCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和黄医药,HCM,和黄医药股票,和黄医药股票老虎,和黄医药股票老虎国际,和黄医药行情,和黄医药股票行情,和黄医药股价,和黄医药股市,和黄医药股票价格,和黄医药股票交易,和黄医药股票购买,和黄医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和黄医药(HCM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和黄医药(HCM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}